Cite
HARVARD Citation
Gutierrez, R. et al. (n.d.). 632. A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550mg daily or twice-daily) for Chemoprophylaxis Against Travelers' Diarrhea Among Deployed U.S. and U.K. Military Personnel (PREVENT TD). Open forum infectious diseases. p. S376. [Online].